fda ruling on tirzepatide update approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA confirms tirzepatide shortage is

The weight is coming off and my appetite is under control

Salivary miRNA tests like EndoTest are now showing over 96% accuracy in large validation studies a true game-changer

If you're not hungry, dont force a mealbut if youre constantly tired or lightheaded, you may not be eating enough

Those on 10 mg lost approximately 19.5%, and the 15 mg group achieved roughly 20.9%

Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury (secondary to dehydration), and hypoglycaemia when used with insulin or sulfonylureas

Gradual Physical Activity While it may feel counterintuitive, light movement often improves fatigue rather than worsening it